Female Infertility denials in California external review

In the California DMHC record, independent physician reviewers decided 21 published external-review cases involving female infertilityand overturned the plan’s denial in 57.1%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
21
2019–2025
Overturned
57.1%
12 denials reversed

Most-fought treatments for female infertility

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Infertility Tx10
60%
SCP Consult Refer3
66.7%
Typical time to a decision
21 days
Most land between 16 and 26 days
Recent direction
Rising
40%80% overturned, last three years

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement for in vitro fertilization (IVF) services: follicle puncture for oocyte retrieval, insemination of oocytes, sperm isolation; complex prep (eg Percoll gradient, albumin gradient) for insemination or diagnosis with semen analysis, oocyte identification from follicular fluid, ultrasonic guidance for aspiration of ova, imaging supervision and interpretation, the culture of oocyte(s) embryo(s) less than 4 days, cryopreservation; embryo, biopsy, oocyte polar body or embryo blastomere, micro technique (for pre-implantation genetic diagnosis) less than or equal to five embryos, and biopsy, oocyte polar body or embryo blastomere, micro technique (for pre-implantation genetic diagnosis) greater than five embryos Findings: The physician reviewer found that the patient clearly meets the guideline definition of infertili…
Medical Necessity · 2025 · IMR MN25-44251
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for the medication regimen for estradiol 0.1 mg transdermal in preparation for the medicated frozen embryo transfer (regimen consisting of: Apply three patches to the abdomen and replace every three days, followed by two patches to the abdomen and replace every three days). The records indicate that this patient underwent frozen embryo transfer (FET) and preparation of the endometrium for implantation. In preparation for FET, estrogen can be given as an oral or a vaginal tablet, a transdermal patch, and a subcutaneous or intramuscular injection.
Medical Necessity · 2024 · IMR MN24-41365

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has been diagnosed with primary female infertility. The submitted documentation reflects that the patient has attempted to become pregnant on two separate occasions by intrauterine insemination (IUI) in 2014 and 2016. These attempts included two IUI and nine IUI cycles, respectively. The patient has stated that she and her husband have been unable to conceive naturally and that IUI is the only thing that has worked for her.
Medical Necessity · 2019 · IMR MN19-30397
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for platelet-rich plasma endometrial infusions. In this case, the patient had intrauterine adhesions that were lysed. She had an abnormal endometrial lining that was inhospitable for embryo implantation. The provider recommended platelet-rich plasma (PRP). Endometrial status is one of the main factors of pregnancy implantation failure. In women with a thin endometrium, PRP may be used as an intrauterine infusion to induce endometrial growth and increase clinical rates of pregnancies.
Experimental/Investigational · 2024 · IMR EI24-42133

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving female infertility, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for female infertility? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9